The purpose of this study is to test the hypothesis that duloxetine (Cymbalta), in doses of
60 or 120 mg/day, is an effective and tolerable treatment for adult outpatients suffering
from dysthymia. Dysthymia is chronic, mild depression characterized by feeling sad or low
more days than not for more than 2 years.